Friendly IVF: patient opinions
|
|
- Molly Bradley
- 6 years ago
- Views:
Transcription
1 Human Reproduction Vol.16, No.7 pp , 2001 Friendly IVF: patient opinions Astrid Højgaard 1,3, Hans Jakob Ingerslev 1 and Jakob Dinesen 2 1 Fertility Clinic and 2 Perinatal Epidemiological Research Unit, Department of Gynaecology and Obstetrics, Aarhus University Hospital, Skejby Sygehus, Aarhus, Denmark 3 To whom correspondence should be addressed at: Fertility Clinic, Skejby Sygehus, DK-8200 Aarhus N, Denmark. astrid.hoejgaard@dadlnet.dk BACKGROUND: The present trend towards low stimulation protocols in IVF calls for evaluation of patient attitudes. METHODS: This study compared results of a 23-item questionnaire mailed to 167 patients receiving a low stimulation type of regimen (L) (unstimulated cycle or clomiphene) and to 116 patients treated by a standard protocol () (long-down regulation with gonadotrophin-releasing hormone analogue and FSH or human menopausal gonadotrophin). RESULTS: Around two-thirds of all responders in both groups deemed sideeffects important, but side-effects and stress associated with hormone treatment were more prevalent in patients receiving than L. Stress due to cycle cancellation was acceptable, mild or not perceptible in significantly (P < 0.005) more patients receiving L [48% (36/75)] compared with patients having [26% (8/31)]. Of patients having tried the L protocol, 93% (125/135) would suggest either L or a sequence of this and as a future treatment package compared with only 53% (33/63) in the group (χ , P < ). The L group showed a significant trend towards acceptance of higher number of treatment cycles. CONCLUSIONS: The patients seemed to prefer the simplicity and short duration of a low stimulation regimen in spite of drawbacks such as a high risk of cycle cancellations and accordingly the necessity for more treatment cycles. Key words: clomiphene citrate/ivf/long down-regulation/unstimulated cycle Introduction cycles, and stress of cancelled cycles in order to point out problem areas and patient preferences in a low stimulation regimen compared with a standard long down-regulation protocol. As unstimulated IVF or low stimulation protocols implies a higher number of cancellations and consequently more treatment cycles (Ingerslev et al., 2001; H.J.Ingerslev et al., unpublished data), this study focused especially on the possible correlation between the number of cycles received and stress reported by the patients. During recent years attention has been given to hormone stimulation regimens less intensive than the long down-regula- tion protocol [gonadotrophin-releasing hormone (GnRH) ana- logue FSH or human menopausal gonadotrophin (HMG)] in order to reduce side-effects, costs, risks and incidence of multiple pregnancy associated with the latter (Edwards et al., 1996; Fleming, 1996; Olivennes and Frydman, 1998). More cycle cancellations seem unavoidably associated with milder stimulation regimens compared to the long down-regulation protocol, but a comparable cumulative clinical pregnancy rate per embryo transfer was recently achieved in IVF using a clomiphene citrate protocol (H.J.Ingerslev et al., unpublished data). There appear to be no previous studies which have analysed patients acceptability of low stimulation protocols. Acceptability can be evaluated by measuring patient satisfac- tion and self-reported levels of stress where patient satisfaction can be defined as the recipient s reaction to the context, process and result of her service experience (Pascoe, 1983) and stress as the perceived meaning of an event and self-appraisal of the adequacy of coping resources (Cohen et al., 1995). Accord- ingly, it was the purpose of the present study to evaluate patients satisfaction and stress associated with each of the two types of protocol in terms of side-effects of hormone treatment, pain at oocyte retrieval, necessity of more treatment Materials and methods Two patient groups receiving either a low stimulation type regimen (clomiphene citrate or unstimulated IVF) or a long down-regulation protocol were approached by a questionnaire. In addition to treatment- specific questions they were asked general questions on subjects related to overall satisfaction with the clinic to evaluate if the two patient groups studied were comparable in this aspect. Low stimulation group (L) Among 564 couples waiting for IVF or intracytoplasmic sperm injection (ICSI) treatment, 196 were invited to participate in a randomized study of IVF in the natural cycle and following clomiphene citrate respectively. Of these, 29 did not respond, 35 were enrolled in a pilot study and finally 132 participated in a randomized study between IVF in unstimulated cycles versus clomiphene citrate stimulation (Ingerslev et al., 2001). For the present study, the 167 patients European Society of Human Reproduction and Embryology 1391
2 A.Højgaard, H.J.Ingerslev and J.Dinesen enrolled in the pilot study and the previously published series were selected, hereafter termed the low stimulation group (L). All Table I. Information in the questionnaire about main characteristics of the fulfilled the following criteria: age 35 years, infertility unexplained, low stimulation (L) and standard protocol () treatment protocols and results tubal or due to severe male factor with indication for ICSI, regular menstrual cycles ( 3 days), presence of two ovaries and no previous IVF treatment. Patient characteristics and principles for randomization L and the two protocols have been presented previously (Ingerslev Mild hormone stimulation (tablets) Strong hormone stimulation (daily et al., 2001). Following closure of the randomized study, all patients injections) were offered further treatments with clomiphene citrate. During 1997 Treatment duration 2 weeks Treatment duration 4 weeks and 1998, the 167 patients received a total of 452 L cycles of Few side-effects More side-effects Few oocytes at oocyte retrieval Many oocytes at oocyte retrieval which 153 were unstimulated IVF cycles and 299 were stimulated High risk of cycle cancellation (40%) Low risk of cycle cancellation with clomiphene citrate. (20%) In short, at entry to the study, patients were randomized by the Pregnancy rate per started Pregnancy rate per started sealed envelope method to either clomiphene citrate (Clomivid ; treatment 18% treatment 30% Astra, Albertslund, Denmark) 100 mg from cycle day 3 to day 7 or Pregnancy rate per embryo Pregnancy rate per embryo transfer 40% transfer 40% to IVF in the unstimulated cycle, but with timing of oocyte retrieval by human chorionic gonadotrophin (HCG) injection. All cycles were monitored by vaginal ultrasound. No routine endocrinology was performed, but from day 9 (unstimulated cycle) or 11 (clomiphene stress throughout IVF treatments. Three staff members at our fertility citrate) the patients were instructed to test a morning urine sample clinic (a nurse, an embryologist and a doctor) developed further for LH by a qualitative test (Clearplan, Unipath Ltd, Bedford, UK). relevant themes. The questions in the final questionnaire related to If positive, HCG was given the same morning and oocyte retrieval the latest treatment cycle (11 questions) and to satisfaction with the was performed the following morning. Oocyte retrieval was performed amount of information (eight questions) and preferences of treatment ultrasound-guided transvaginally with a single-lumen needle (Cook, (three questions). Finally, respondents were encouraged to comment Brisbane, Australia, 16G) 30 min after the patient had taken 1 g of on the treatment. Scores were measured on a five-point Likert-type paracetamol and 10 mg of diazepam orally. No other analgesia was scale. Satisfaction concerning information was rated on a scale as offered routinely. Laboratory culture and ICSI were performed as follows: very satisfied, satisfied, neutral/do not know, dissatisfied, previously described (Ingerslev et al., 2001). A maximum of two very dissatisfied. The respondents were asked to characterize the embryos were transferred by a Cook, catheter. No luteal phase information given as: too optimistic, realistic or too pessimistic. support was given. Measurement of serum HCG was performed Stress, physical pain and side-effects were rated in the following way: 2 weeks later and concentrations of 20 IU/l were considered unacceptably severe, severe, acceptable, mild, none. The importance of positive. Pregnant patients were routinely scanned 5 weeks after a question was measured on a three-point scale: very important, embryo transfer. important and unimportant. Since the patients in the two groups had no experience as to the alternative treatment protocol, a short neutral Long down-regulation or standard IVF group () description of L and regimens was offered in the Among all couples having received their first and subsequent IVF questionnaire (Table I). cycles following the long down-regulation protocol (GnRH analogue In a pilot study 10 couples were interviewed after having fulfilled and FSH or HMG) at our clinic during 1996, 1997 and 1998, 116 the questionnaire. It was confirmed that the topics were considered couples fulfilled the same criteria as outlined above for the L important and final alterations were made to the questionnaire. group (H.J.Ingerslev et al., unpublished data). The 116 women had Enclosed with the questionnaire was a stamped addressed envelope a total of 190 treatments during the period. and a letter in which the aims of the study were described, anonymity Following down-regulation by Suprefact (Hjechst Marion Roussel, was guaranteed and it was emphasized that participation was voluntary. Stockholm, Sweden) nasal spray (six times per day) from cycle day Non-responders were not r ed. 21 in the previous cycle, ovarian stimulation with FSH or HMG Statistical analysis [Humegon, Puregon (Organon, Oss, The Netherlands) or Gonal- The results of the questionnaire and background data were entered F ; Serono SA, Madrid, Spain] started 2 weeks later postmenstrually in a Statistics Package for Social Sciences (SPSS) database and at a standard dose of 150 IU per day. Follicular development was analysed by SPSS software. Bivariate associations were tested with monitored by vaginal ultrasound and HCG (Pregnyl ; Organon) was Student s t-test for continuous outcomes, and the χ 2 -test for independgiven h before oocyte collection at a follicular diameter of ence within contingency tables for dichotomous outcome. Statistical leading follicle(s) of 18 mm. Oocyte retrieval was performed under i.v. significance was defined as two-sided P The risk difference sedation with midazolam ( mg) and pethidine (25 50 mg) is presented with 95% confidence intervals (CI). and a paracervical block with lidocaine. Oocyte handling, ICSI and embryo culture and transfer was performed as previously described (Ingerslev et al., 2001). Luteal support was given i.v. as progesterone Results (Progestan ; Organon) 100 mg four times daily until the pregnancy The response rate was significantly higher in the L group test and, if that was positive, until the pregnancy ultrasound 3 (141/167 84%) compared with the group (66/116 weeks later. 57%; χ ; odds ratio (OR) 4.1; 95% CI ; P ). Questionnaire A 23-item questionnaire was designed in a process involving the General questions following steps. The literature was reviewed in order to identify The two responder groups showed a comparable and high issues of particular importance concerning the patient satisfaction and satisfaction (very satisfied or satisfied) with the written informa- 1392
3 Friendly IVF and patient acceptance Table II. Experiences of and attitudes to side-effects of hormone treatment L Table III. Experiences of, and attitudes to, pain associated with oocyte retrieval How were the side-effects of the hormone treatment? Unacceptable/severe (%) 4/75 (5) a 38/63 (60) How was the pain associated with the last oocyte retrieval? Acceptable/mild/not perceptible (%) 71/75 (95) 25/63 (40) Unacceptable/severe 45/130 (35) a 27/64(42) How important are side-effects for your overall view of treatment? Acceptable/mild/not perceptible (%) 85/130 (65) 37/64 (58) Important/very important (%) 59/101 (58) b 39/64 (61) How important is pain for your overall view of treatment? Unimportant (%) 42/101 (42) 25/64 (39) Important/very important (%) 51/127 (40) b 37/65 (57) How was the stress associated with hormone treatment? How was the level of stress associated with oocyte retrieval? Unacceptable/severe (%) 2/73 (3) c 15/65 (23) Unacceptable/severe (%) 38/131 (29) c 20/64 (31) Acceptable/mild/none (%) 71/73 (97) 50/65 (77) Acceptable/mild/not perceptible (%) 93/131 (71) 44/64 (69) L a χ [odds ratio (OR) 27.0; 95% confidence interval (CI) ; a χ , not significant (NS). P 0.001]. b b χ (OR 2.0; 95% CI ; P 0.03). χ (not significant). c c χ (NS). χ (OR 10.7; 95% CI ; P 0.001). L low stimulation IVF; standard IVF. L low stimulation IVF; standard IVF. the two groups (Table II). The total stress of the hormone tion given [L 137/141 (97%) versus 65/66 (98%)] treatment was acceptable, little or not perceptible by 97% and verbal information from the doctors [L 126/140 (71/73) of the L patients compared with 77% (50/65) of (90%) versus 58/65 (89%)], nurses [L 139/140 the patients (Table II). There was no significant differ- (99%) versus 64/65 (99%)] and embryologists [L ence between pregnant versus non-pregnant responders in 134/140 (96%) versus 60/64 (94%)]. Equal proportions either group regarding severity and importance of side-effects of couples in the two groups evaluated the information as (data not shown). satisfactory [L 139/141 (99%) versus 64/66 Pain (97%)] and the expectations of the two treatments from the Among all patients, 12/194 (6%) reported unacceptable pain information given to be realistic [L 131/141 (93%) (Table III). Although similar proportions of patients in the two versus 61/65 (94%)]. Accordingly, there was no apparent groups had experienced a very painful last oocyte retrieval bias in the self-selection of the responders in terms of general [L 45/130 (%) and 27/64 (42%)], they had satisfaction to items not directly related to the treatment. different views on the importance of pain. Significantly more The mean number of started cycles was 1.86 in the L patients in the control group regarded pain at oocyte group and 1.69 in the group. In the last treatment cycle, retrieval as an important factor influencing their view of the 72/139 (52%) of the responders in the L group had treatment than in the L group (Table III). The total stress embryos transferred compared with 59/65 (91%) in the connected with the oocyte aspiration procedure was the same group. These values are similar to those in the total series in the two groups, being acceptable, mild or not perceptible [L 201/452 (44%) versus 164/190 (86%)]. Accordingly, in a large majority of the patients [93/131 (71%) versus the responder group was representative of all the patients 44/64 (69%)] (Table III). The reported pain at oocyte retrieval in the two groups in both cases in terms of completed cycles. in both groups was of no difference in pregnant and non- In the latest cycle a positive pregnancy test was obtained pregnant responders (data not shown). by 25% (31/123) of L responders, significantly higher than the average pregnancy rate of 14% (61/452) in that group Attitudes connected to cycle cancellation and repeated cycles (χ ; OR 2.2; 95% CI ). In the group The stress due to cancellation of a cycle was reported acceptable, these values were 60% (39/65) and 31% (59/190; χ ; mild or not perceptible by a significantly higher proportion OR 3.3; 95% CI ). There was no significant difference of the patients in the L group [36/75 (48%)] compared between pregnant versus non-pregnant responders in either with the group [8/31 (26%)] (χ ; OR 2.7; 95% group in terms of satisfaction with the information given (data CI ; P 0.005). not shown). In the L group there were no changes in perception of severity of hormone side-effects with increasing number of Specific questions related to the two treatments cycles started. A large majority of patients still found sideeffects Side-effects acceptable even after two or three cycles (data not Among 75 L patients who had been treated with clomi- shown). In the treatment group, however, side-effects phene, few deemed side-effects unacceptable or severe but were more commonly reported as severe if exposed to treatment more than half of the patients in the group did so more than once (one treatment cycle 15/31 versus more than (Table II). The patients were asked about what importance one cycle 22/30; χ ; OR 2.9; 95% CI ; hormone side-effects had for their general view of the particular P 0.005). The opinion on pain seemed to be independent treatment. Hormone side-effects were assessed to be important of number of treatment cycles in both groups and the pain or very important by a comparable proportion of patients in reported was independent of number of oocytes aspirated (data 1393
4 A.Højgaard, H.J.Ingerslev and J.Dinesen Table IV. Preferences of future treatments according to treatment experienced Table V. Answers to question on how many of either low stimulation (L) cycles and standard protocol () treatments the patients would like to go through before giving up IVF treatment Would you suggest L patients patients No. of treatments before L patients (%) patients (%) giving up L treatment (%) 50 (37%) a 3 (5) treatment (%) 10 (7) b 30 (48) L Combination of the two (%) 75 (56) c 30 (48) 3 22/93 (24) 12/21 (57) Total /93 (66) 5/21 (24) a χ [odds ratio (OR) 11.8; 95% confidence interval (CI) ; 3 37/49 (76) 23/39 (59) P 0.001]. 6 8/49 (16) 11/39 (28) b χ (OR 0.1; 95% CI ; P ). c χ (not significant). Preference of 6 LS cycles in L versus patients, χ L low stimulation IVF; standard IVF. (OR 6.1; 95% CI ; P 0.001). Preference of 3 cycles in L versus patients, χ (not significant). not shown). There was no significant difference between pregnant versus non-pregnant responders in terms of attitudes number of L cycles (Table V). On the other hand, both to cycle cancellation (data not shown). groups preferred a limited number of cycles ( 3). The same trends were evident when the patients were asked Preference for mode of treatment in the future to indicate how many of either treatment type they would Being presented with crude statements about the two protocols prefer in a sequential combination of the two (data not shown). (Table I), the patients were asked about preferences of either protocol or a combination of the two protocols (for example, two L trials followed by two trials). Both groups Discussion preferred the treatment that they had experienced (Table IV). The main object of this study was to evaluate how the patients In both groups about half of patients would suggest a combination balance advantages and disadvantages of low stimulation of the two regimens. However, 93% (125/135) of the regimens in terms of unstimulated cycles or clomiphene for patients having tried the L protocol would suggest either IVF versus a long down-regulation protocol with GnRH L or a sequence of this and compared with only analogue and FSH. In broad terms, it was found that the 53% (33/63) in the group (χ ; OR 11.4; 95% patients seem to counterbalance the disadvantages of low CI ; P ). stimulation (less efficiency per cycle, more cancellations) by In the L group 74% (23/31) of responders with a the apparent advantages (e.g. few side-effects, short duration, positive pregnancy test opted for L in comparison with simplicity). 20% (17/86) of responders with a negative pregnancy test Primary domains of satisfaction with fertility treatment are (χ ; OR 11.7; 95% CI ; P ). Among general satisfaction with the clinic, number, duration and responders the future choices were not influenced by results of treatment and information regarding treatment type, the results of the treatment (data not shown). side-effects and prognosis (Sabourin et al., 1991), all of which In patients having had L, preference for treatment were different in the two treatment protocols in the present protocol was associated with the perceived pain at the latest study. IVF treatment is stressful (Collins et al., 1992) and oocyte retrieval. Thus, there was a trend to prefer alone unsuccessful treatment causes grievance and anxiety compar- or a combination of and L if the last oocyte able with that seen following pregnancy loss (Greenfield et al., retrieval had been painful [77% (33/43)] compared with 55% 1988). The most stressful time points during the procedure are (45/82) if pain was acceptable (χ ; OR 2.7; 95% CI oocyte retrieval, embryo transfer and the 2 week waiting ; P 0.02). The choices in the group were not period until the pregnancy test (Connolly et al., 1993; Boivin associated with the severity of pain at the last oocyte retrieval, et al., 1998), which are all experienced more frequently in an although this group had indicated pain as an important factor L protocol. influencing their view of the treatment. In comparison with IVF with GnRH analogue FSH, L or a combination was preferred by 83% (76/92) of low stimulation regimens require more cycles to obtain a patients who considered hormone side-effects as important, comparable pregnancy rate, primarily due to a higher cycle compared with 68% (45/66) who did not (χ ; OR 2.2; cancellation rate. Accordingly, the patients must undergo a 95% CI ; P 0.05). higher number of hormone treatment cycles and oocyte aspiration When the patients in the two groups were asked to decide procedures (Ingerslev et al., 2001; H.J.Ingerslev et al., how many of either L cycles or treatments they unpublished data). Low stimulation regimens, on the other could accept in case no pregnancy was achieved to go hand, are associated with less prominent hormone side-effects, through before giving up IVF treatment, there was a significant a minimal risk of ovarian hyperstimulation syndrome, a much trend for the L group to prefer a high number ( 6) of shorter duration of treatment and a reduction of the risk of L cycles, whereas the group preferred a lower multiple pregnancies. 1394
5 Friendly IVF and patient acceptance All respondents were generally satisfied with the information satisfaction and number of treatment commencements did not given. From other studies it is known that information is a reach significance (Sabourin et al., 1991). main topic of satisfaction with infertility management (Halman The questionnaire was designed to give an answer to the et al., 1993; Souter et al., 1998). question of whether a less efficient and thus often repeated The higher response rate to the questionnaire in the L treatment with a mild stimulation protocol is more or less group compared with the group may be explained by a stressful than a more efficient standard protocol with heavier higher motivation for a new approach in the former group. stimulation and side-effects. A significantly larger proportion This fact and a relative over-representation of patients with of patients found cycle cancellations stressful in the positive pregnancy tests among responders in both groups may group compared to the L group. The lesser cancellation be borne in mind in the interpretation of the results of this study. stress reported in the L group may in part be explained Hormone side-effects were found to be important by a large by the fact that there was no limit to the number of treatment majority of all responders irrespective of treatment experienced cycles in this group, while patients were only entitled and are thus a main point of interest. A majority of patients to three completed cycles. Nevertheless, a majority of in the group, but few of the patients receiving clomiphene patients preferred a limit of three cycles. Thus, in the citrate in the L group, reported severe side-effects. L group there was a marked tendency to accept more With increasing number of cycles the burden of adverse effects treatments than in the group. This indicates that repeated in the group was more intolerable. No such tendency treatments cycles are acceptable within a low stimulation could be shown in the L group where almost no patients protocol. reported side-effects. The fact is that a rather high proportion of L cycles The information on side-effects in Table I given to all are cancelled, primarily due to spontaneous ovulation (14%) couples as a part of the questionnaire represents a possible and fertilization failure (21%) (H.J.Ingerslev et al., unpublished bias towards the L protocol. The reason for presenting data). GnRH antagonists may be useful to obviate risk of Table I in the questionnaire was that the patients had experi- spontaneous ovulation in low stimulation protocols. ences with only one of the two treatment protocols. In order In conclusion, the present study indicates that a majority of to indicate preferences they had to be briefly informed about the infertile patients seem to accept the drawbacks of low the main differences between the two protocols in order to stimulation regimens in terms of cycle cancellations and make a more informed assessment of the options. The informa- accordingly the necessity of more treatment cycles against the tion was rather schematic. The response rate of 96% is advantages of such protocols in terms of few side-effects, interpreted as a sign of high motivation and thus validity. simplicity and short duration. These data thus demonstrate that In the current study, pain at oocyte retrieval was almost a large proportion of the patients are motivated for low identical in the two groups in spite of absence of i.v. analgesia stimulation protocols as an integrated part of available protocols administered in the L group. This could not be attributed for IVF. to the fact that L patients had fewer oocytes, as the severity of pain was independent of number of oocytes. While Acknowledgements a majority of patients regarded pain as important, LS- IVF patients claimed pain to be of less importance. Nevertheless The authors wish to thank clinical, paramedical and laboratory staff at the Fertility Clinic at Skejby Sygehus and at The Perinatal L patients showed a marked preference to treat- Epidemiological Research Unit, especially Marianne Leth and Bente ment if the last oocyte retrieval had been painful. A possible Jespersen for participation in the development of the questionnaire. explanation for this could be that L patients, knowing We are very grateful to The Danish Institute for Health Technology that they were participating in a study, wanted to retreat to a Assessment for funding (project no ). well-known treatment protocol when experiencing a stressful event such as a painful oocyte retrieval. Another possible References explanation could be that patients who experience a painful Abbey, A., Halman, L.J. and Andrews, F.M. (1992) Psychosocial, treatment oocyte retrieval may have a wish to optimize outcome of and demographic predictors of the stress associated with infertility. Fertil. this stage of the treatment procedure. This may reflect the Steril., 57, Boivin, J., Andersson, L., Skoog-Svanberg, A. et al. (1998) Psychological importance of a sufficient analgesia to this group and that reactions during in-vitro fertilization: similar response in husbands and painful oocyte retrieval seems to be a predictor of compliance wives. Hum. Reprod., 13, with treatment. On the other hand there was no sign of change Cohen, S.J., Kessler, R.C. and Underwood, G.L. (1995) Strategies for measuring stress in studies of psychiatric and physical disorders. In Cohen, in the perception of pain after several unsuccessful treatment S.J., Kessler, R.C., Underwood, G.L. (eds), Measuring Stress: A Guide for cycles. Oocyte retrieval can thus be repeated without increasing Health and Social Scientists. Oxford University Press, New York, pp the burden of unsuccessful treatments in L patients. Collins, A., Freeman, E.W., Boxer, A.S. and Tureck, R. (1992) Perceptions Previous studies have shown that first and third treatment of infertility and treatment stress in females as compared with males entering in vitro fertilization treatment. Fertil. Steril., 2, cycles are the most stressful (Slade et al., 1997). After an Connolly, K.J., Edelmann, R.J., Bartlett, H. et al. (1993) An evaluation of unsuccessful treatment cycle, 25% of women have a mild or counselling for couples undergoing treatment for in-vitro fertilization. Hum. moderate depression (Newton et al., 1990). The higher the Reprod., 8, Edwards, R.G., Lobo, R. and Bouchard, P. (1996) Time to revolutionize number of unsuccessful treatment cycles, the more stress ovarian stimulation. Hum. Reprod., 11, (Abbey et al., 1992; Connolly et al., 1993). However, in a Fleming, R. (1996) Time to revolutionize ovarian stimulation. Hum. Reprod., consumer satisfaction study the association between patient 11,
6 A.Højgaard, H.J.Ingerslev and J.Dinesen Greenfeld, D.A., Diamond, M.P. and Decherney, A.H. (1988) Grief reactions Pascoe, G.C. (1983) Patient satisfaction in primary health care: a literature following IVF treatment. J. Psychosom. Obstet. Gynecol., 8, review and analysis. Eval. Prog. Planning, 6, 185. Halman, J.L., Abbey, A. and Andrews, F.M. (1993) Why are couples satisfied Sabourin, S. Wright, J., Duchesne, C. et al. (1991) Are consumers of modern with infertility treatment? Fertil. Steril., 5, fertility treatments satisfied? Fertil. Steril., 6, Ingerslev, H.J., Højgaard, A., Hindkjaer, J. et al. (2001) A randomized study Slade, P., Emery, J. and Lieberman, B.A. (1997) A prospective, longitudinal comparing IVF in the unstimulated cycle with IVF following clomiphene study of emotions and relationships in in-vitro fertilization treatment. Hum. citrate. Hum. Reprod., 16, Reprod., 12, Newton, C.R., Hearn, M.T. and Yuzpe, A.A. (1990) Psychological assessment Souter, V.L. Penney, G., Hopton, J.L. et al. (1998) Patient satisfaction with and follow-up after in-vitro fertilization: assessing the impact of failure. the management of infertility. Hum. Reprod., 13, Fertil. Steril., 5, Olivennes, F. and Frydman, R. (1998) Friendly IVF: the way of the future? Hum. Reprod., 13, Received on November 1, 2000; accepted on March 19,
Modified natural cycle IVF and mild IVF: a 10 year Swedish experience
Reproductive BioMedicine Online (2010) 20, 156 162 www.sciencedirect.com www.rbmonline.com ARTICLE Modified natural cycle IVF and mild IVF: a 10 year Swedish experience Arthur Aanesen *, Karl-Gösta Nygren,
More informationThe psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy
Human Reproduction Vol.22, No.9 pp. 2554 2558, 2007 Advance Access publication on June 23, 2007 doi:10.1093/humrep/dem171 The psychological impact of IVF failure after two or more cycles of IVF with a
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationClinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.
UvA-DARE (Digital Academic Repository) Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G. Link to publication Citation for published version (APA): Al-Inany,
More informationA mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort
Chapter 6 A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R.,
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationRelation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy
Relation between the Number and Size of Follicles in Ovulation Induction and the Rate of Pregnancy Aseel Mosa Jabber M.SC.G.O. The department of Obstetrics and Gynecology, Faculty of Medicine Thi-qar university
More informationin vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo
More informationIs the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion
F, V & V IN OBGYN, 2010, MONOGRAPH: 36-41 Artificial insemination Is the fallopian tube better than the uterus? Evidence on intrauterine insemination versus fallopian sperm perfusion Arne SUNDE 1, Jarl
More informationCumulative probability of live birth after three in vitro fertilization/intracytoplasmic sperm injection cycles
FERTILITY AND STERILITY VOL. 77, NO. 3, MARCH 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Cumulative probability
More informationMinimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age
FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Minimal stimulation using recombinant
More informationA Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist
1 *, ** * * * ** A Case of Pregnancy Using Recombinant Follicle Stimulating Hormone and Gonadotropin Releasing Hormone Antagonist Yoon Sung Nam, Nam Keun Kim*, Eun Kyung Kim**, Hyung Min Chung** and Kwang
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationPatient-staff communication and its effect on reactions to treatment and treatment failure
Patient-staff communication and its effect on reactions to treatment and treatment failure Published in: Boivin, J. (2000). Patient staff communication and its effect on reactions to treatment and treatment
More information2013 Sep.; 24(3):
Journal of Reproduction & Contraception doi: 10.7669/j.issn.1001-7844.2013.03.0159 2013 Sep.; 24(3):159-172 E-mail: randc_journal@163.com Comparison of the Effects and Safety of Mild Ovarian Stimulation
More informationMenstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
Human Reproduction Vol.21, No.4 pp. 1012 1017, 2006 Advance Access publication December 8, 2005. doi:10.1093/humrep/dei415 Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists
More informationArticle Use of a fully automated injector for selfadministration
RBMOnline - Vol 11. No 4. 2005 415 420 Reproductive BioMedicine Online; www.rbmonline.com/article/1832 on web 15 August 2005 Article Use of a fully automated injector for selfadministration of follitropin
More informationNew York Science Journal 2014;7(4)
The Minimal Stimulation Protocol for ICSI: An Alternative Protocol for Ovarian Stimulation Adel Elsayed Ibrahim, MD Assisted Reproductive Unit Azhar University Adel.sayed29@gmail.com Abstract: Background:
More informationIVF Patient Information
What is IVF? IVF (In Vitro Fertilisation) is a treatment by which fertilisation of eggs by sperm takes place outside the body in a dish in an IVF laboratory. An ovary has a pool of immature eggs. In a
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationNatural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR)
Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR) Geeta Nargund Head of Reproductive Medicine St George s Hospital London ISMAAR Terminology Human Reprod Nargund et al
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationRelationships in couples after failed IVF treatment: a prospective follow-up study
Human Reproduction Page 1 of 6 Hum. Reprod. Advance Access published March 24, 2005 doi:10.1093/humrep/deh882 Relationships in couples after failed IVF treatment: a prospective follow-up study Gunilla
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationElena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a
FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Predictive usefulness of cycle
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 September 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 September 2010 100 µg/0.5 ml, solution for injection B/1 prefilled syringe + 1 needle (CIP code: 374 590-1) 150
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationPatient Information: Patient Name: Date of Birth:
Weill Cornell Medicine Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Informed Consent for Oocyte (Egg) Cryopreservation Patient Information: Part 1: I have requested to be treated
More informationPerformance of patients with a ''frozen pelvis" in an in vitro fertilization program
FERTILITY AND STERILITY Copyright 1987 The American Fertility Society Printed in U.8A. Performance of patients with a ''frozen pelvis" in an in vitro fertilization program David Molloy, F.R.A.C.O.G.*t
More informationMilan Reljič, Ph.D., Veljko Vlaisavljević, Ph.D., Vida Gavrić, M.Sc., Borut Kovačič, Ph.D.,
FERTILITY AND STERILITY VOL. 75, NO. 3, MARCH 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Value of the serum estradiol
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationIntrauterine donor insemination in single women and lesbian couples: a comparative study of pregnancy rates
Human Reproduction vol.15 no.3 pp.621625, 2000 Intrauterine donor insemination in single women and lesbian couples: a comparative study of pregnancy rates I.Ferrara 1, R.Balet 2 and J.G.Grudzinskas 1,2,3
More informationThe psychological influence of gender infertility diagnoses among men about to start IVF or ICSI treatment using their own sperm
Human Reproduction Vol.22, No.9 pp. 2559 2565, 2007 Advance Access publication on June 27, 2007 doi:10.1093/humrep/dem189 The psychological influence of gender infertility diagnoses among men about to
More informationLOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS
LOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS Salem H. H. '; Nassar A. M.,&l ; Askalany N. A. ', Kassem K. 1&4 Department of Obstetrics and Gynecology Al Azhar
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationUtility of in vitro fertilization at diagnostic laparoscopy*
FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.
More informationSchedule of Fees for Private Treatment
Schedule of Fees for Private Treatment Fertility Treatment is personalized to each individual and couple, based on diagnosis and best treatment options. At Fertility Plus, we are mindful of the costs involved
More informationAbstract. Introduction. Materials and methods. Patients and methods
RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos
More informationIn Vitro Fertilization and Embryo Transfer
Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,
More informationArticle Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment
RBMOnline - Vol 7. No 2. 185 189 Reproductive BioMedicine Online; www.rbmonline.com/article/900 on web 18 June 2003 Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix,
More informationFirst IVF treatment short-term impact on psychological well-being and the marital relationship
Human Reproduction Vol.21, No.12 pp. 3295 3302, 2006 Advance Access publication August 24, 2006. doi:10.1093/humrep/del288 First IVF treatment short-term impact on psychological well-being and the marital
More informationClinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin in Normogonadotropic Infertile Patients
International Reproductive Medicine Volume 2013, Article ID 135258, 4 pages http://dx.doi.org/10.1155/2013/135258 Clinical Study Clinical Effects of a Natural Extract of Urinary Human Menopausal Gonadotrophin
More informationGonadotrophin treatment in patients with Polycystic Ovary Syndrome
Int. J. Adv. Res. Biol. Sci. (218). 5(4): 95-99 International Journal of Advanced Research in Biological Sciences ISSN: 2348-869 www.ijarbs.com DOI: 1.22192/ijarbs Coden: IJARQG(USA) Volume 5, Issue 4-218
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationA prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
FVV IN OBGYN, 2012, 4 (2): 82-87 Original paper A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF S. GORDTS,
More informationAsimina Tavaniotou 1, Carola Albano 1, Johan Smitz 1 and Paul Devroey 1,2
Human Reproduction Vol.16, No.4 pp. 663 667, 2001 Comparison of LH concentrations in the early and midluteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist
More informationHana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang
Original Article Obstet Gynecol Sci 2015;58(6):481-486 http://dx.doi.org/10.5468/ogs.2015.58.6.481 pissn 2287-8572 eissn 2287-8580 Effect of second-line surgery on in vitro fertilization outcome in infertile
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationMinimal monitoring / Minimal stimulation as a means of increasing access to ART in developing countries
Minimal monitoring / Minimal stimulation as a means of increasing access to ART in developing countries Willem Ombelet Genk Institute for Fertility Technology Maribor, 27-02-09 Third World = overpopulation
More informationAbstract. Introduction. Materials and methods
RBMOnline - Vol 10. No 5. 2005 645 649 Reproductive BioMedicine Online; www.rbmonline.com/article/1518 on web 18 March 2005 Article Factors predicting IVF treatment outcome: a multivariate analysis of
More informationIndividualized treatment based on ovarian reserve markers
Individualized treatment based on ovarian reserve markers Prof Dr. Nikolaos P. Polyzos M.D. PhD Professor and Medical Co- Director, Vrije Universiteit Brussel, UZ Brussel, Belgium Professor of Reproduc?ve
More informationNICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic
NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in
More informationInformation Booklet. Exploring the causes of infertility and treatment options.
Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole
More informationArticle Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination
RBMOnline - Vol 13. No 2. 2006 208-212 Reproductive BioMedicine Online; www.rbmonline.com/article/2334 on web 30 May 2006 Article Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine
More informationLink between effectiveness and cost data The costing was undertaken prospectively on the same patient sample that provided the effectiveness data.
Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-fsh vs. HPuFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis Revelli A, Poso F, Gennarelli
More information- Meta. : (rfsh); (ufsh); (IVF); : R711.6 : A : X(2015) : hmg( FSH LH) [ufsh, (ufsh-p) (ufsh-hp)] (rfsh) [1] 80, rfsh, 90, :
35 2 Vol.35 No.2 2015 2 Feb. 2015 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2015.02.0099 E-mail: randc_journal@163.com (FSH) - Meta FSH ( 400010) : (IVF) (ICSI) (rfsh) (ufsh) (COS) : PubMed
More informationEffect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial
FULL PROJECT TITLE: Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial (STimulation Resulting in Embryonic Aneuploidy using Menopur (STREAM)
More informationPredictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older
Reprod Med Biol (2009) 8:145 149 DOI 10.1007/s12522-009-0023-z ORIGINAL ARTICLE Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Akihisa
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationORIGINAL ARTICLE ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOME IN IUI CYCLES
ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOME IN IUI CYCLES Asha Verma 1, Rekha Mulchandani 2, Nupur Lauria 3, Kusum Verma 4, Sunita Himani 5 HOW TO CITE THIS ARTICLE: Asha Verma, Rekha Mulchandani, Nupur
More informationPerceptions of infertility and treatment stress in females as compared with males entering in vitro fertilization treatment*
FERTILITY AND STERILITY Copyright 1992 The American Fertility Society Vol. 57. No.2. February 1992 Printed on acid-free paper in U.S.A. Perceptions of infertility and treatment stress in females as compared
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More informationThe influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients
Human Reproduction Vol.17, No.5 pp. 1207 1211, 2002 The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients Sheila Loh
More informationPatient Overview: Invitro Fertilisation
Patient Overview: Overview IVF stands for in-vitro fertilisation i.e. literally fertilisation in a glass dish. You may also hear the term ART used which stands for Assisted Reproductive Technologies. IVF
More informationWhy do couples drop-out from IVF treatment? A prospective cohort study
Human Reproduction Vol.23, No.9 pp. 2050 2055, 2008 Advance Access publication on June 10, 2008 doi:10.1093/humrep/den219 Why do couples drop-out from IVF treatment? A prospective cohort study M.F.G. Verberg
More informationUse of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to friendly IVF?
Human Reproduction Vol.17, No.8 pp. 2022 2026, 2002 Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to friendly IVF? J.B.Engel, M.Ludwig 1, R.Felberbaum,
More informationInfertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF
Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility
More informationConsent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition
Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Patient Name (please print) Patient DOB (MM/DD/YYYY) Patient eivf number Partner
More informationUse of clomiphene to prevent premature luteinizing hormone surge during controlled ovarian hyper stimulation
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Bhandari S et al. Int J Reprod Contracept Obstet Gynecol. 2016 Jun;5(6):1944-1948 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationIn Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome
Original Article Effect of Laparoscopic Ovarian Drilling on Outcomes of In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome Maryam Eftekhar, M.D. 1, Razieh Deghani Firoozabadi,
More informationMinimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S
Minimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S Record Status This is a critical abstract of an economic
More informationA prospective randomized study comparing aspiration only with aspiration and flushing for transvaginal ultrasound-directed oocyte recovery
FERTILITY AND STERILITY Vol. 58, No.2, August 1992 Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. A prospective randomized study comparing aspiration only with aspiration
More informationLaboratoires Genevirer Menotrophin IU 1.8.2
Important missing information VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Infertility is when a woman cannot get pregnant (conceive) despite having regular unprotected sexual
More informationThe outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology
Human Reproduction vol.14 no.1 pp.167 171, 1999 The outcome of in-vitro fertilization treatment in women with sonographic evidence of polycystic ovarian morphology Lawrence Engmann 1,2,5, Noreen Maconochie
More informationEffects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment
FERTILITY AND STERILITY VOL. 74, NO. 5, NOVEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effects of functional
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness Gerli S, Casini M L, Unfer V, Costabile L, Bini V,
More informationVanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.
Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol
More informationK.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1
Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Applicable Injectable Fertility Medications: Bravelle, Cetrotide, Follistim AQ, Ganirelix, Gonal-F, human chorionic gonadotropin, leuprolide, Menopur, Novarel, Ovidrel, Pregnyl,
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationPituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H.
UvA-DARE (Digital Academic Repository) Pituitary down-regulation in IVF/ICSI: consequences for treatment regimens Mochtar, M.H. Link to publication Citation for published version (APA): Mochtar, M. H.
More informationDrug Therapy Guidelines
Drug Therapy Guidelines Applicable Medical Benefit Effective: 8/15/18 Pharmacy- Formulary 1 x Next Review: 6/18 Pharmacy- Formulary 2 x Date of Origin: 7/00 Injectable Fertility Medications: Bravelle,
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationArticle Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study
RBMOnline - Vol 13. No 2. 2006 166-172 Reproductive BioMedicine Online; www.rbmonline.com/article/2261 on web 19 May 2006 Article Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study
More informationCancer Risks of Ovulation Induction
Cancer Risks of Ovulation Induction 5th World Congress on Ovulation Induction September 13-15, 2007 Louise A. Brinton, Ph.D. National Cancer Institute Rockville, Maryland, USA Ovulation Induction and Cancer
More informationAnti-Mullerian hormone (AMH) as predictor of ovarian reserve
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Shembekar CA et al. Int J Reprod Contracept Obstet Gynecol. 2017 Sep;6(9):4006-4010 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174053
More informationIVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman
IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major
More informationConsultations and Assessment Fertility Specialist consultation 180 Ultrasound scan of uterus and ovaries 100 AMH measurement 80 Semen analysis 100
We hope this price list will help you assess the cost of your consultations, investigations and treatment. It provides information about what is included in the cost and how we make a refund if your treatment
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More information2017 United HealthCare Services, Inc.
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017
More informationAge and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome
British Journal of Obstetrics and Gynaecology January 1998, Vol. 105, pp. 107-1 12 Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome Khaldoun Sharif Lecturer, Manal
More informationOocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments
IN VITRO FERTILIZATION Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments Daniela Nogueira, Ph.D., a Shevach
More informationScientific Highlights: First world conference on luteinizing hormone in ART: Landing in Asia Pacific
This EXCEMED conference followed on from the First world conference on luteinizing hormone (LH) in ART, which took place in Naples in May 2016. Bringing the topic of LH to Asia Pacific provided an opportunity
More information